List of cloud penetration stocks [Ichimoku Kinko Hyo - List of cloud penetration stocks]

○ List of stocks breaking through the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1301> Kyokuyo 4285 4278.75 4182.5 <1417> Mirait One 2308 2230 292.5 <1721> Comsys HD 3265 3247.5 3248.5 <1929> Nittoku Construction 1055 1050.5 1032.5 <1979> Taiki Corporation 2370 2345.

Fisco JapanMay 9 06:29

Kissei Pharmaceutical Reports Strong Fiscal 2024 Performance With Strategic Market Expansion

TipRanksMay 8 15:33

Kissei Pharmaceutical: Financial results briefing materials for the fiscal year ending 2025/3

JPXMay 8 15:00 · Announcements

Stocks that moved and those that were traded in the front market.

*NTT Data <9613> 3492 - It has been reported that NTT will fully acquire the company. *Tori Pharmaceutical <4551> 6340 +760 - Movement towards aligning with the TOB price implemented by Shionogi. *Nojima <7419> 3130 +260 - Positive outlook continues due to significantly better earnings. *DMG Mori Seiki <6141> 2669 +192 - Significant profit decrease in the first quarter, but a sense of security due to steady order trends. *Yokogawa Electric <6841> 3273 +200 - Previous period strong performance and dividend increase plan.

Fisco JapanMay 8 12:49

Kissei Pharmaceutical Completes Treasury Share Acquisition and Plans Cancellation

TipRanksMay 8 09:23

Kissei Pharmaceutical surged, responding positively to the outlook for increased profits and dividends as well as the Share Buyback.

Kissei Pharmaceutical Industry <4547.T> surged sharply. It opened with a buying indication, briefly reaching 4,200 yen, a 390 yen increase compared to the previous day. After the close on the 7th, it disclosed its financial results for the fiscal year ending March 2025 and its performance estimates for the fiscal year ending March 2026. Additionally, it announced a new share buyback program and a new medium-term management plan, which attracted buying interest. The consolidated operating profit for the fiscal year ending March 2025 is estimated at 5.773 billion yen, a 43.7% increase from the previous year. In addition to the overactive bladder treatment medication 'Beovarb tablets', microscopic polyangiitis and polyangiitis...

Kabushiki ShimbunMay 8 09:13